Nuveen’s AMAG Pharmaceuticals AMAG Stock Holding History

Nuveen’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-149,004	Closed	-$1.4M	–	3394
2020 Q3	$1.4M	Buy	149,004 +15,622	+12%	+$148K	﹤0.01%	2532
2020 Q2	$1.02M	Sell	133,382 -194,986	-59%	-$1.49M	﹤0.01%	2616
2020 Q1	$2.03M	Sell	328,368 -24,450	-7%	-$215K	﹤0.01%	2180
2019 Q4	$4.29M	Sell	352,818 -165,371	-32%	-$1.81M	﹤0.01%	2065
2019 Q3	$5.99M	Sell	518,189 -173,545	-25%	-$1.83M	﹤0.01%	1867
2019 Q2	$6.91M	Buy	+691,734	New	+$7.46M	﹤0.01%	1817

Nuveen's AMAG Position: Q4 2020 in Review

Nuveen sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 149,004 shares — an estimated $1.4M sold.

Nuveen first reported a position in AMAG in Q2 2019 and held it in 6 quarters. The position peaked at $6.91M in Q2 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Nuveen reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Nuveen sold 149,004 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.4M.
Nuveen first reported a position in AMAG Pharmaceuticals in Q2 2019 and held it in 6 quarters.
Nuveen's AMAG Pharmaceuticals position peaked at $6.91M in Q2 2019.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.